Dividends vs the 4% Rule: What Happens Over 20 Years
Retirees with a $500,000 portfolio face a choice between dividend-driven income and the traditional 4% rule. Early da...
What Does 2024 Total Market Return Mean
This intro clarifies what 2024 Total Market Return implies for portfolios, taxes, and long-term planning in plain language.
28,280 articles
FedEx First Major Company Sues for Full Tariff Refund
FedEx filed a lawsuit seeking a full refund of IEEPA duties, arguing harmed by the government orders. This move marks...
Iran Forces DoorDash to Pay $50M for Driver Relief
Geopolitical tensions push fuel costs higher, prompting DoorDash to fund more than $50 million in gas-price relief fo...
The $260k College Mistake: Parent’s Retirement Risk
A 49-year-old mother considers tapping home equity to fund a $65k-per-year college. The decision could push retiremen...
$500? Dirt-Cheap Dividend Powerhouse Under $5 to Buy
As volatility eases, income-focused investors eye a dirt-cheap dividend powerhouse trading under $5. The article expl...
Best Dividend Stocks Hold: Two Reliable Forever Picks
If you're building a nest egg that could outlive you, you need dependable income and durable brands. Here are two div...
After Issuing More Tariff Refunds, U.S. Halts CAPE
The Trump administration faces a court-backed pause on universal tariff refunds, even as more than $20 billion has al...
This Artificial Intelligence (AI) Stock Could Surpass Nvidia
The AI infrastructure boom has Nvidia leading, but Alphabet's end-to-end AI stack and TPU ecosystem could reshape the...
France Will Take Home World Cup Prize as Mbappé Donates
As the 2026 World Cup unfolds, France stands to collect a sizable prize pot regardless of results. Meanwhile, Mbappé ...
Protect Your Portfolio From Jamie Dimon's Skunk in a Party
Inflation can crash a party you didn’t RSVP to. Learn a practical, step-by-step approach to shield your investments f...
Crispr Therapeutics Editas Medicine: Better Buy in 2026?
Two top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
Vertex Paying 102% Premium: Is the Crinetics Deal Worth It?
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status